GTF2H2C_2
gene geneOn this page
Also known as LOC730394
Summary
GTF2H2C_2 (GTF2H2 family member C, copy 2, HGNC:35418) is a protein-coding gene on chromosome 5q13.2 alternate reference locus, encoding General transcription factor IIH subunit 2-like protein (Q6P1K8). Component of the core-TFIIH basal transcription factor involved in nucleotide excision repair (NER) of DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II.
Predicted to enable zinc ion binding activity. Predicted to be involved in nucleotide-excision repair and regulation of transcription by RNA polymerase II. Located in nuclear speck.
Source: NCBI Gene 730394 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001354437
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35418 |
| Approved symbol | GTF2H2C_2 |
| Name | GTF2H2 family member C, copy 2 |
| Location | 5q13.2 alternate reference locus |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC730394 |
| Ensembl gene | ENSG00000274675 |
| Entrez | 730394 |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 4 — MANE Select: NM_001354437
NM_001042490, NM_001354437, NM_001354438, NM_001354439
Canonical transcript exons
ENST00000621406 — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | no | 255.05 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
General transcription factor IIH subunit 2-like protein — Q6P1K8 (reviewed: Q6P1K8)
Alternative names: General transcription factor IIH polypeptide 2-like protein
All UniProt accessions (3): Q6P1K8, D6RAW1, D6RJD3
UniProt curated annotations — full annotation on UniProt →
Function. Component of the core-TFIIH basal transcription factor involved in nucleotide excision repair (NER) of DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II.
Subcellular location. Nucleus.
Similarity. Belongs to the GTF2H2 family.
RefSeq proteins (4): NP_001035955, NP_001341366, NP_001341367, NP_001341368 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002035 | VWF_A | Domain |
| IPR004595 | TFIIH_C1-like_dom | Domain |
| IPR007198 | Ssl1-like | Domain |
| IPR012170 | TFIIH_SSL1/p44 | Family |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036465 | vWFA_dom_sf | Homologous_superfamily |
| IPR046349 | C1-like_sf | Homologous_superfamily |
Pfam: PF04056, PF07975
UniProt features (5 total): chain 1, domain 1, zinc finger region 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P1K8-F1 | 84.05 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 95
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
GOBP_NUCLEOTIDE_EXCISION_REPAIR, GOBP_DNA_DAMAGE_RESPONSE, GOCC_RNA_POLYMERASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS, GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX, GOCC_NUCLEAR_SPECK, GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX, GOCC_TRANSFERASE_COMPLEX, GOCC_NUCLEAR_BODY, GOCC_PROTEIN_KINASE_COMPLEX, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, GOCC_RIBONUCLEOPROTEIN_GRANULE, GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX, GOBP_DNA_METABOLIC_PROCESS, GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX
GO Biological Process (5): nucleotide-excision repair (GO:0006289), DNA-templated transcription (GO:0006351), regulation of transcription by RNA polymerase II (GO:0006357), DNA repair (GO:0006281), DNA damage response (GO:0006974)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): transcription factor TFIIH core complex (GO:0000439), transcription factor TFIIH holo complex (GO:0005675), nuclear speck (GO:0016607), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulator complex | 2 |
| DNA repair | 1 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA metabolic process | 1 |
| DNA damage response | 1 |
| cellular response to stress | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| transcription factor TFIIH core complex | 1 |
| RNA polymerase II, holoenzyme | 1 |
| nuclear cyclin-dependent protein kinase holoenzyme complex | 1 |
| carboxy-terminal domain protein kinase complex | 1 |
| nuclear ribonucleoprotein granule | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
862 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GTF2H2C_2 | GTF2H3 | Q13889 | 797 |
| GTF2H2C_2 | GTF2H1 | P32780 | 770 |
| GTF2H2C_2 | ERCC3 | P19447 | 754 |
| GTF2H2C_2 | GTF2H4 | Q92759 | 738 |
| GTF2H2C_2 | ERCC8 | Q13216 | 684 |
| GTF2H2C_2 | ERCC1 | P07992 | 671 |
| GTF2H2C_2 | SERF1A | O75920 | 583 |
| GTF2H2C_2 | ERCC2 | P18074 | 572 |
| GTF2H2C_2 | MNAT1 | P51948 | 542 |
| GTF2H2C_2 | CDK7 | P50613 | 530 |
| GTF2H2C_2 | NAIP | Q13075 | 506 |
| GTF2H2C_2 | FAM72B | Q86X60 | 474 |
| GTF2H2C_2 | SMN1 | Q16637 | 474 |
| GTF2H2C_2 | DHRS4L2 | Q6PKH6 | 473 |
| GTF2H2C_2 | TCAF1 | Q9Y4C2 | 461 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTF2H1 | CDK7 | psi-mi:“MI:0915”(physical association) | 0.820 |
| GTF2H3 | GTF2H2C | psi-mi:“MI:0915”(physical association) | 0.800 |
| GTF2H2C | GTF2H3 | psi-mi:“MI:0915”(physical association) | 0.800 |
| GTF2H3 | ERCC3 | psi-mi:“MI:0914”(association) | 0.640 |
| ERCC2 | GTF2H2C | psi-mi:“MI:0915”(physical association) | 0.560 |
| DZIP3 | GTF2H2C | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2H2C | ERCC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2H2C | DZIP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2H2C | FAM43A | psi-mi:“MI:0915”(physical association) | 0.560 |
| NR5A2 | GTF2H2C | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2H2C | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2H2C | ERCC3 | psi-mi:“MI:0914”(association) | 0.530 |
| DYNLRB2 | PAFAH1B1 | psi-mi:“MI:0914”(association) | 0.510 |
| SUV39H1 | GTF2H2C | psi-mi:“MI:0915”(physical association) | 0.370 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| CCDC40 | VAPB | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| GTF2H2C | GTF2H2C | psi-mi:“MI:0914”(association) | 0.350 |
| PRDM11 | ERCC3 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK7 | ACACB | psi-mi:“MI:0914”(association) | 0.350 |
| CDC7 | ERCC1 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK7 | ERCC1 | psi-mi:“MI:0914”(association) | 0.350 |
| GTF2H4 | TUSC2 | psi-mi:“MI:0914”(association) | 0.350 |
| GTF2H4 | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| EAF1 | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| HIRIP3 | GPX1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (92): GTF2H2C_2 (Two-hybrid), GTF2H2C_2 (Two-hybrid), GTF2H2C_2 (Two-hybrid), GTF2H2C (Affinity Capture-MS), GTF2H1 (Affinity Capture-MS), GTF2H3 (Affinity Capture-MS), GTF2H4 (Affinity Capture-MS), ERCC3 (Affinity Capture-MS), PTS (Affinity Capture-MS), GALC (Affinity Capture-MS), GTF2H2C (Co-fractionation), GTF2H2C (Co-fractionation), GTF2H2C (Co-fractionation), GTF2H2C_2 (Co-fractionation), GTF2H2C_2 (Co-fractionation)
ESM2 similar proteins: A0A1L8F5J9, A0JN27, F1LTR1, F1NBL0, O15294, P35438, P35439, P56558, P61201, P61202, P61203, P61599, P61600, P63138, P79101, P81436, Q03555, Q05586, Q13888, Q15303, Q27HV0, Q2PFM2, Q2TBV5, Q4L208, Q58ED9, Q5R1P0, Q5SP67, Q5ZJ75, Q61527, Q62956, Q6IQT4, Q6IR75, Q6P1K8, Q6P632, Q7ZXR3, Q8BUV3, Q8C6G8, Q8CGY8, Q8R4D1, Q91854
Diamond homologs: A0JN27, O74995, P34567, Q04673, Q13888, Q2TBV5, Q6P1K8, Q86KZ2, Q9JIB4, Q9ZVN9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| GTF2H2C | “form complex” | TFIIH | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 34 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 7 | 114.2× | 9e-12 |
| RNA Pol II CTD phosphorylation and interaction with CE | 7 | 114.2× | 9e-12 |
| mRNA Capping | 7 | 106.6× | 1e-11 |
| Formation of the Early Elongation Complex | 7 | 94.0× | 1e-11 |
| Formation of the HIV-1 Early Elongation Complex | 7 | 94.0× | 1e-11 |
| RNA Polymerase I Transcription Termination | 7 | 91.4× | 2e-11 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 5 | 91.4× | 1e-08 |
| Formation of Incision Complex in GG-NER | 8 | 81.2× | 7e-12 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| nucleotide-excision repair | 8 | 98.8× | 3e-12 |
| transcription initiation at RNA polymerase II promoter | 5 | 60.4× | 2e-06 |
| DNA repair | 7 | 14.4× | 4e-05 |
| transcription by RNA polymerase II | 6 | 13.7× | 3e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000330265 (5:71063919 A>C), RS1000927154 (5:71056263 G>C,T), RS1002328080 (5:71061435 C>T), RS1002931893 (5:71039973 A>G), RS1004375051 (5:71050736 G>A), RS1004810720 (5:71046348 A>C,G), RS1006464156 (5:71054969 T>C), RS1006891994 (5:71056093 T>C), RS1006926714 (5:71055231 T>C), RS1008471915 (5:71036515 TG>T), RS1008565273 (5:71063822 G>A), RS1008594959 (5:71061658 CT>C,CTT), RS1010264733 (5:71059415 G>A,C), RS1010574096 (5:71051944 T>C), RS1010606648 (5:71051209 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | decreases expression | 1 |
| Gold | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.